文献速递腹部介入CT

生物力学可变形配准与自动分割量化结直肠肝转移消融边缘

Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation.
PubMed 文献 · Radiology · 2023-01-31

单中心回顾性研究纳入124例患者213个结直肠肝转移灶,采用基于AI自动分割和生物力学可变形图像配准的CT方法量化三维最小消融边缘(MAM)。结果显示MAM≥5 mm者无局部进展,MAM=0 mm者2年累积局部进展发生率达72%,MAM 0 mm是局部进展的独立危险因素。

要点

  • 消融后CT确认MAM≥5 mm可作为局部肿瘤控制的理想终点。
  • MAM=0 mm者局部进展风险显著增高,2年累积发生率达72%。
  • MAM 0~<5 mm者仍有一定局部进展风险,需密切随访。

核心结论

  • 基于CT的生物力学可变形图像配准联合AI自动分割可识别并空间定位消融后高危局部进展的结直肠肝转移灶。
  • 最小消融边缘≥5 mm为最佳终点,MAM=0 mm与局部疾病进展独立相关。

研究设计与样本

  • 单机构回顾性研究,纳入2015年10月至2020年3月接受CT引导微波或射频消融的124例连续结直肠肝转移患者共213个消融灶。
  • 采用生物力学可变形图像配准方法,结合AI自动分割肝脏、肿瘤及消融区,回顾性量化三维最小消融边缘。
  • 局部疾病进展定义为残留肿瘤或局部肿瘤进展,采用多变量Fine-Gray竞争风险模型分析相关因素,中位随访25.8个月。

关键影像表现/征象

  • 消融灶MAM为0 mm者占14.6%(31/213),>0至<5 mm者占40.4%(86/213),≥5 mm者占45.1%(96/213)。
  • MAM=0 mm者2年累积局部疾病进展发生率为72%,MAM>0至<5 mm者为12%,MAM≥5 mm者未见局部进展。
  • 117个MAM<5 mm的肿瘤中36个出现局部进展,其中30个经三维射线追踪定位于距肿瘤<5 mm的高风险组织内。

诊断标准与关键数值

  • 最小消融边缘(MAM)分级:0 mm、>0至<5 mm、≥5 mm,对应2年累积局部进展发生率分别为72%、12%、0%。
  • 多变量分析显示MAM=0 mm与局部疾病进展独立相关(亚分布风险比23.3,95%CI:10.8, 50.5,P < .001)。
  • MAM≥5 mm为最佳终点,未观察到局部疾病进展。

临床应用与阅片要点

  • 消融后应利用可变形配准和自动分割量化三维最小消融边缘,而非仅凭肉眼评估。
  • 报告时应明确MAM数值并分级,MAM=0 mm者提示局部进展风险极高,需密切随访。
  • MAM<5 mm者即使>0 mm也存在局部进展风险,应结合三维空间定位关注高风险组织区域。

局限性

  • 单中心回顾性研究设计。
  • 样本量及随访时间有限,结论需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Confirming ablation completeness with sufficient ablative margin is critical for local tumor control following colorectal liver metastasis (CLM) ablation. An image-based confirmation method considering patient- and ablation-related biomechanical deformation is an unmet need. Purpose To evaluate a biomechanical deformable image registration (DIR) method for three-dimensional (3D) minimal ablative margin (MAM) quantification and the association with local disease progression following CT-guided CLM ablation. Materials and Methods This single-institution retrospective study included patients with CLM treated with CT-guided microwave or radiofrequency ablation from October 2015 to March 2020. A biomechanical DIR method with AI-based autosegmentation of liver, tumors, and ablation zones on CT images was applied for MAM quantification retrospectively. The per-tumor incidence of local disease progression was defined as residual tumor or local tumor progression. Factors associated with local disease progression were evaluated using the multivariable Fine-Gray subdistribution hazard model. Local disease progression sites were spatially localized with the tissue at risk for tumor progression (<5 mm) using a 3D ray-tracing method. Results Overall, 213 ablated CLMs (mean diameter, 1.4 cm) in 124 consecutive patients (mean age, 57 years ± 12 [SD]; 69 women) were evaluated, with a median follow-up interval of 25.8 months. In ablated CLMs, an MAM of 0 mm was depicted in 14.6% (31 of 213), from greater than 0 to less than 5 mm in 40.4% (86 of 213), and greater than or equal to 5 mm in 45.1% (96 of 213). The 2-year cumulative incidence of local disease progression was 72% for 0 mm and 12% for greater than 0 to less than 5 mm. No local disease progression was observed for an MAM greater than or equal to 5 mm. Among 117 tumors with an MAM less than 5 mm, 36 had local disease progression and 30 were spatially localized within the tissue at risk for tumor progression. On multivariable analysis, an MAM of 0 mm (subdistribution hazard ratio, 23.3; 95% CI: 10.8, 50.5; P < .001) was independently associated with local disease progression. Conclusion Biomechanical deformable image registration and autosegmentation on CT images enabled identification and spatial localization of colorectal liver metastases at risk for local disease progression following ablation, with a minimal ablative margin greater than or equal to 5 mm as the optimal end point. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Sofocleous in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lin, Paolucci, O'Connor, et al. Ablative Margins of Colorectal Liver Metastases Using Deformable CT Image Registration and Autosegmentation. Radiology. 2023. PMID: 36719291. doi:10.1148/radiol.221373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。